Skip to main content

EDITORIAL article

Front. Psychiatry
Sec. Addictive Disorders
Volume 15 - 2024 | doi: 10.3389/fpsyt.2024.1443304
This article is part of the Research Topic Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era View all 5 articles

Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era

Provisionally accepted
  • 1 Indivior, Inc., Richmond, United States
  • 2 Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, United States
  • 3 Centre for Addiction and Mental Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

The final, formatted version of the article will be published soon.

    Keywords: Opioid overdose crisis, synthetic opioids, Fentanyl, Carfentanil, Naloxone, Nalmefene, Cardiac arrest and brain injuries, Respiratory depression (RD)

    Received: 03 Jun 2024; Accepted: 05 Jul 2024.

    Copyright: © 2024 Heidbreder, Greenwald, Le Foll and Skolnick. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Christian Heidbreder, Indivior, Inc., Richmond, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.